Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis

BMC Health Services Research, Journal Year: 2022, Volume and Issue: 22(1)

Published: Aug. 8, 2022

Despite extensive evidence that COVID-19 symptoms may persist for up to a year, their long-term implications healthcare utilization and costs 6 months post-diagnosis remain relatively unexplored. We examine patient-level association of diagnosis with average monthly medical expenditures months, explore heterogeneity across age groups determine how many patients above pre-diagnosis levels.

Language: Английский

---

Negative effects of high public debt on health systems facing pandemic crisis: Lessons from COVID-19 in Europe to prepare for future emergencies

AIMS Public Health, Journal Year: 2024, Volume and Issue: 11(2), P. 477 - 498

Published: Jan. 1, 2024

<p>The investigation goal here was to analyze how the level of public debt affects preparedness health systems face emergencies. In particular, this study examined negative effects high on European countries in presence COVID-19 pandemic crisis. Empirical evidence revealed that with a lower government as percentage GDP both 2009 and 2019 (the period before arrival pandemic) had fatality rates compared higher levels debt. The explanation is trigger budget constraints limit their ability allocate resources healthcare (e.g., expenditures investments), weakening system performance causing systemic vulnerability during emergencies, such pandemic. Implications policies are suggested improve strategies crisis management.</p>

Language: Английский

---

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States

Journal of Medical Economics, Journal Year: 2023, Volume and Issue: 26(1), P. 1532 - 1545

Published: Nov. 14, 2023

Aims To assess the potential clinical impact and cost-effectiveness of COVID-19 mRNA vaccines updated for fall 2023 in adults ≥18 years over a 1-year analytic time horizon (September 2023-August 2024).

Language: Английский

---

Latinx LGBTQ Youth, COVID-19, and Psychological Well-Being: A Systematic Review

Journal of Clinical Child & Adolescent Psychology, Journal Year: 2023, Volume and Issue: 53(1), P. 98 - 113

Published: Jan. 23, 2023

Objective As a result of the COVID-19 pandemic, Latinx youth report high rates negative mental health outcomes such as anxiety and depression. Similarly, research with lesbian, gay, bisexual, transgender, queer (LGBTQ) have documented increased depression pandemic. However, current literature has yet to systematically uncover intersectional experiences LGBTQ during this time.Method We conducted systematic review Our resulted in 14 empirical studies that explored challenges, stressors, impact pandemic on youth.Results Findings revealed most include cisgender, gender binary, heterosexual, youth. across include: (a) from school closures, (b) (c) online media, (d) family cultural values source support stress, (e) implementation evaluation interventions pandemic.Discussion provide recommendations for clinicians working including expanding their knowledge about these communities, considering multifaceted, role heterogeneity Youth.

Language: Английский

---

COVID-19 status and utilisation of essential maternal and child healthcare services during the pandemic in Ahmedabad, India

BMC Pregnancy and Childbirth, Journal Year: 2025, Volume and Issue: 25(1)

Published: Jan. 30, 2025

Access to essential healthcare services is pertinent the achievement of universal health coverage in any nation. The COVID-19 lockdown was used mitigate spread pandemic. Consequently, there a reduction Utilisation Basic Healthcare Services (UBHS) diverse dimensions. However, variation existed UBHS by status, but extent this disparity has not been extensively addressed Ahmedabad, India. Therefore, study explores relationship between status and utilisation maternal child during pandemic A mixed-method approach for data (both quantitative qualitative) collection from November 2021 October 2022. Four zones were purposefully selected 6 Ahmedabad. part included pregnant women or those who had baby delivery April 2020 (n = 278), while 10 these participated qualitative part. Data analysed using descriptive statistics, Chi-square test, binomial logistic regression (α 0.05). deductive analyse data. Of total 278, almost 43% infected with their pregnancy. Women tested positive availed lesser antenatal care (ANC), Postnatal (PNC). There experiences documented regarding access without are more likely receive services, such as visits workers [aOR 2.59 (1.03- 6.49)], counseling 1.92 (0.61- 6.06)], at planned place 1.98 (0.99- 3.92)] compared positive. be accompanied labor ([aOR 2.91(1.04- 8.11) appropriate birth spacing counselling 1.38 (0.7-2.71)]. lower among not. Social system determinants disrupting fear infection unavailability workforce. Health planners policymakers encouraged take into consideration findings building resilient managing future pandemics.

Language: Английский

---

The incidence of outpatient care within 24 months from SARS-CoV-2 infection in the general population: a multicenter population-based cohort study

BMC Infectious Diseases, Journal Year: 2025, Volume and Issue: 25(1)

Published: Jan. 30, 2025

Abstract Background The long-term effects of COVID-19, which can vary significantly in type and timing, are considered relevant impacting on the well-being individuals. present study aims to assess incidence outpatient care post-acute phase SARS-CoV-2 infection two Italian regions. Methods has a multicentre, population-based, pre-post, repeated measures design compare rate access visits diagnostics before after infection, considering follow-up 24 months. made use previously recorded large-scale healthcare data available administrative databases Emilia-Romagna (E-R) Veneto Analyses were carried out separately regions results pooled using random meta-analysis. Results There 27,140 subjects E-R 22,876 who included analysis. outputs showed an increase rates starting from month 2 (IRR = 1.68, 95% CI 1.56–1.81) with peak at 4 2.05, 1.95–2.15); continued reduced intensity up 15. Stratified analysis revealed that severe acute COVID-19 had higher (up IRR 3.96, 2.89–5.44), as well patients no comorbidities 2.71, 2.60–2.83). Conclusion Long-term include burden especially first months infection. increased demand for resources last years particular subgroups such admitted hospital during due presentation disease.

Language: Английский

---

High- and Low-Cost Healthcare Utilization for Cancer and COVID-19 Patients

COVID, Journal Year: 2025, Volume and Issue: 5(4), P. 56 - 56

Published: April 16, 2025

Background: Healthcare total spending accelerated during the COVID-19 pandemic. Understanding broad high- and low-cost healthcare utilization while system is under stress can help identify strategies gaps to improve future quality of care reducing high-cost maximizing care. Methods: This was a population-based cross-sectional study with 56,141 individuals in U.S. using 2020–2021 Medical Expenditure Panel Survey (MEPS) data sources. We applied Poisson regression approach test differences among patients with/without cancer/COVID-19 outcomes, including emergency department (ED) visits, inpatient discharge, nights stay, outpatient home provider days. Results: Outpatient visits were affected by both cancer diagnoses (86% 109% higher for and/or COVID-19, p < 0.001). had statistically significant increases care, (1) ED (151% 245% higher, 0.001), (2) number (94% 170%, 0.001, (3) stay (259% 268% There no home-based when compared without COVID-19. Conclusions: Improving adopting innovative are critical reduce strengthen pandemic preparedness.

Language: Английский

---

Exploring the diverse factors influencing healthcare utilization during the COVID-19 crisis

Frontiers in Public Health, Journal Year: 2025, Volume and Issue: 13

Published: May 16, 2025

Background The emergence of the COVID-19 pandemic created an unprecedented global health crisis, resulting in major disruptions to healthcare systems worldwide. has also significantly reshaped utilization patterns. This study aimed assess during three waves COVID-19. Methods We conducted a retrospective involving 1,308 patients admitted care facility at National Institute Medical Sciences and Research Jaipur, Rajasthan, India. analyzed patterns first, second, third COVID-19, focusing on patient hospitalization duration across waves. Results rate increased second wave compared first subsequently declined wave. Hospitalization durations varied In all waves, 30% population was hospitalized for 0–5 days, 25.9% 9–13 24.08% 6–8 19.5% were more than 14 days. A p -value 0.032 indicated statistically significant difference length hospital stay (LHS) threshold p-value 0.05 used estimate future requirements similar scenarios. Conclusion Our findings highlight dynamic nature demands underscore need flexible capable adapting fluctuating loads. Proactive planning resource allocation are crucial managing pandemics effectively.

Language: Английский

---

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: Sept. 7, 2023

Abstract Objectives To assess the potential clinical impact and cost-effectiveness of COVID-19 mRNA vaccines updated for Fall 2023 in adults ≥18 years over a 1-year analytic time horizon (September 2023-August 2024). Methods A compartmental Susceptible-Exposed-Infected-Recovered model was to reflect summer 2023. Numbers symptomatic infections, related hospitalizations deaths, costs quality-adjusted life-years (QALYs) gained were calculated using decision tree model. The incremental ratio (ICER) Moderna vaccine (Moderna Campaign) compared no additional vaccination. Potential differences between Pfizer-BioNTech examined. Results Base case results suggest Campaign would decrease expected 64.2 million infections by 7.2 (11%) 57.0 million. COVID-19-related deaths are decline 343,000 (–29%) 50,500 (–33%), respectively. increase QALYs 740,880 healthcare $5.7 billion relative No Vaccine, yielding an ICER $7,700 per QALY gained. Using societal cost perspective, is $2,100. Sensitivity analyses that effectiveness, incidence, hospitalization rates drive cost-effectiveness. With effectiveness (rVE) versus 5.1% infection 9.8% hospitalization, use prevent 24,000 more 3,300 than vaccine. Limitations Conclusions As becomes endemic, future including patterns infection, highly uncertain. Vaccine unknown, it unclear when new variant evades natural or immunity will emerge. Despite these limitations, can be considered cost-effective

Language: Английский

---

Exploring Long COVID: Healthcare Utilization Up to 360 Days after a COVID-19 Diagnosis—Results from Analysis of a Very Large US National Sample

Health, Journal Year: 2023, Volume and Issue: 15(02), P. 177 - 185

Published: Jan. 1, 2023

The topic of the long-term effects COVID-19, so-called "long-COVID", has gained increased attention. US federal government announced plans to develop an interagency national research action plan uncover more insights into COVID-19. This study contributes our understanding COVID-19 by quantifying patterns healthcare utilization up 360 days after initial diagnosis occurring during beginning pandemic (March-August 2020) in a very large nationally representative population insured adults. We quantify actual COVID-19-related (as opposed reported symptoms) accessing claims data calculate average medical visits per patient month type encounter (e.g. inpatient stay, physician visit). In contrast many recent reports media, results show that declines substantially first-month post-diagnosis and continues decline throughout period low levels.

Language: Английский

---